ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

ClinicalTrials.gov ID: NCT06588283

Public ClinicalTrials.gov record NCT06588283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)

Study identification

NCT ID
NCT06588283
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
250 participants

Conditions and interventions

Interventions

  • Ixekizumab Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2024
Primary completion
Jan 7, 2026
Completion
Apr 30, 2026
Last update posted
Jan 19, 2026

2024 – 2026

United States locations

U.S. sites
68
U.S. states
26
U.S. cities
60
Facility City State ZIP Site status
Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology Birmingham Alabama 35203
Medical Dermatology Specialists Phoenix Arizona 85006
Scottsdale Clinical Trials Scottsdale Arizona 85260
Yuma Clinical Trials Yuma Arizona 85365
Johnson Dermatology Fort Smith Arkansas 72916
California Dermatology & Clinical Research Institute Encinitas California 92024
First OC Dermatology Research Inc Fountain Valley California 92708
Avance Clinical Trials Laguna Niguel California 92677
Metropolis Dermatology Los Angeles California 90017
Dermatology Research Associates Los Angeles California 90045
Northridge Clinical Trials Northridge California 91325
Cura Clinical Research - Oxnard Oxnard California 93030
Integrative Skin Science and Research - Location 2 Sacramento California 95815
Therapeutics Clinical Research San Diego California 92123
Life Clinical Trials Coral Springs Florida 33071
Alliance for Multispecialty Research, LLC Fort Myers Florida 33912
NeoClinical Research Hialeah Florida 33016
Skin Care Research Hollywood Florida 33021
Encore Medical Research Hollywood Florida 33024
Solutions Through Advanced Research Jacksonville Florida 32256
Deluxe Health Center Miami Lakes Florida 33014
Renstar Medical Research Ocala Florida 34470
Leading Edge Dermatology Plantation Florida 33317
International Clinical Research - Sanford Sanford Florida 32771
Nodal Medical Center Tampa Florida 33607
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research Tampa Florida 33609
DeNova Research Chicago Illinois 60602
Oak Dermatology Naperville Illinois 60563
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168
Equity Medical - Bowling Green Bowling Green Kentucky 42104
DelRicht Research Baton Rouge Louisiana 70809
Care Access - Lake Charles (Bayou Pines) Lake Charles Louisiana 70601
Dermatology and Skin Cancer Specialists, LLC Rockville Maryland 20850
Lawrence J. Green, MD, LLC Rockville Maryland 20850
Great Lakes Research Group, Inc. Bay City Michigan 48706
The Derm Institute of West Michigan Caledonia Michigan 49316
MI Skin Innovations Northville Michigan 48167
Las Vegas Dermatology Las Vegas Nevada 89144
Skin Cancer and Dermatology Institute - Reno Reno Nevada 89509
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520
Care Access - Hoboken Hoboken New Jersey 07030
Equity Medical New York New York 10023
Mount Sinai Doctors - East 85th Street New York New York 10028
Onsite Clinical Solutions - Huntersville Huntersville North Carolina 28078
Red River Research Partners Fargo North Dakota 58103
Optima Research - Boardman Boardman Ohio 44512
Dermatologists of Southwest Ohio Mason Ohio 45040
Oregon Medical Research Center Portland Oregon 97201
Oregon Dermatology and Research Center Portland Oregon 97210
Dermatology Associates of Plymouth Meeting Plymouth Meeting Pennsylvania 19462
Columbia Dermatology & Aesthetics Columbia South Carolina 29212
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130
DelRicht Research - Thompson's Station Smyrna Tennessee 37167
Tekton Research - Westlake Drive Austin Texas 78746
Bellaire Dermatology Associates Bellaire Texas 77401
Modern Research Associates, PLLC Dallas Texas 75231
Austin Institute for Clinical Research Pflugerville Texas 78660
Progressive Clinical Research San Antonio Texas 78213
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Tanner Clinic Layton Utah 84041
Care Access - Arlington Arlington Virginia 22206
Care Access - Danville Danville Virginia 24541
Virginia Clinical Research, Inc. Norfolk Virginia 23502
Bellevue Dermatology Clinic Bellevue Washington 98004
Dermatology of Seattle Burien Washington 98168

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06588283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06588283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →